Krishna Kannan

Title: **Innovator Profile: Krishna Kannan**

Introduction

Krishna Kannan is an accomplished inventor based in Boulder, Colorado, recognized for his contributions to the field of biotechnology. With two patents to his name, he has made significant strides in enhancing genetic editing technology, particularly within yeast cells. His innovative work reflects a commitment to advancing scientific research and applications.

Latest Patents

Krishna's latest patent focuses on "Increased nucleic-acid guided cell editing in yeast." This patent outlines methods to increase the percentage of edited yeast cells within a population using nucleic-acid guided editing techniques. The patent also describes the design of automated multi-module instruments that facilitate the implementation of these methods, showcasing a blend of technological innovation and practical application.

Career Highlights

Currently, Krishna Kannan works at Inscripta, Inc., a company that leads the charge in advancing gene editing technologies. His role there allows him to apply his expertise in molecular biology and genetic engineering, further pushing the boundaries of what is possible in biotechnology.

Collaborations

Throughout his career, Krishna has collaborated with notable professionals in the field, including his coworkers Miles Gander and Eileen Spindler. These collaborations highlight a collective effort to drive innovation and improve methodologies in DNA editing.

Conclusion

Krishna Kannan stands out as a notable inventor in the realm of biotechnology, with a focus on enhancing genetic editing technologies. His patents not only contribute to scientific advancement but also pave the way for future research and applications in genetic engineering. With a strong foundation in collaboration and innovation, Krishna continues to be an influential figure in his field.